TRK inhibition for pediatric and adult central nervous system tumors: Early promise and future questions

Neuro Oncol. 2022 Jun 1;24(6):1008-1009. doi: 10.1093/neuonc/noac048.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adult
  • Central Nervous System Neoplasms* / drug therapy
  • Child
  • Humans
  • Pyrazoles
  • Pyrimidines*

Substances

  • Pyrazoles
  • Pyrimidines
  • larotrectinib